Provided by Tiger Trade Technology Pte. Ltd.

BRII-B

1.480
+0.0100.68%
Volume:1.73M
Turnover:2.55M
Market Cap:1.07B
PE:-1.88
High:1.500
Open:1.470
Low:1.440
Close:1.470
52wk High:3.090
52wk Low:1.080
Shares:722.00M
HK Float Shares:722.00M
Volume Ratio:1.55
T/O Rate:0.24%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.786
ROE:-14.42%
ROA:-8.42%
PB:0.38
PE(LYR):-1.88
PS:32.86

Loading ...

Company Profile

Company Name:
BRII-B
Exchange:
SEHK
Establishment Date:
2017
Employees:
96
Office Location:
Building 7, International Science Park,3rd Floor, Zhongguancun Dongsheng,No. 1 North Yongtaizhuang Road,Haidian District,Beijing,China
Zip Code:
100192
Phone:
- -
Fax:
- -
Introduction:
Brii Biosciences Ltd is a biotechnology company primarily engaged in the development of therapies for infectious diseases and central nervous system diseases. The Company's main products include BRII-179, a candidate drug for hepatitis B virus (HBV) immunotherapy, Tobevibart, an investigational neutralizing monoclonal antibody targeting hepatitis B surface antigen (HBsAg), as well as soralimixin (BRII-693), a synthetic lipopeptide for treating multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacterial infections. The Company primarily operates its businesses in the domestic market.

Directors

Name
Position
Zhi Hong
Chairman of the Board,Executive Director,Member of the Nomination Committee
LI An Kang
Executive Director,Chairman of the Strategic and Development Committee
Grace Hui TANG
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit and Risk Management Committee Chairman
TSUI Yiu Wa Alec
Independent Director,Member of the Remuneration and Assessment Committee,Audit and Risk Management Committee Member
Gregg H. Alton
Independent Director,Member of the Strategic and Development Committee,Chairman of the Nomination Committee
Martin J Murphy JR
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee
YANG Tai Ying
Independent Director,Member of the Strategic and Development Committee,Audit and Risk Management Committee Chairman

Shareholders

Name
Position
Zhi Hong
CEO
Eleanor (Ellee) de Groot
Vice General Manager,CTO
Aleksandar Skuban
Vice General Manager,Other Senior Executives
LIANG Xu
Vice General Manager,Other Senior Executives
LI An Kang
CFO,Corporate Secretary
HE Yong Zi
Corporate Secretary
Brian Alvin Johns
Chief Science Officer
XU Lian Hong
Other Senior Executives
ZHU Qing
Other Senior Executives,Other Senior Executives
Jean-Luc Samuel Francois GIRARDET
Other Senior Executives
Lisa Trivison BECK
Other Senior Executives
David Margolis
Other Senior Executives,Other Senior Executives
Karen D. Neuendorff
Other Senior Executives
Susannah Cantrell
Other Senior Executives